Pacific Europlast India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-06-2024
- Paid Up Capital ₹ 0.50 M
as on 21-06-2024
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -31.64%
(FY 2016)
- Profit 23.03%
(FY 2016)
- Ebitda 269.19%
(FY 2016)
- Net Worth 24.03%
(FY 2016)
- Total Assets -18.35%
(FY 2016)
About Pacific Europlast India
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Jain and Saroj serve as directors at the Company.
- CIN/LLPIN
U25194DL2009PTC189439
- Company No.
189439
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pacific Europlast India Private Limited offer?
Pacific Europlast India Private Limited offers a wide range of products and services, including Office Partitions, Aluminum Office Partition, UPVC Windows, UPVC Sliding Windows, Door & Window Hinges, Butt Hinges.
Who are the key members and board of directors at Pacific Europlast India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Jain  | Director | 16-Apr-2009 | Current |
| Saroj | Director | 15-Jan-2010 | Current |
Financial Performance of Pacific Europlast India.
Pacific Europlast India Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 31.64% decrease. The company also saw a substantial improvement in profitability, with a 23.03% increase in profit. The company's net worth Soared by an impressive increase of 24.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pacific Europlast India?
In 2017, Pacific Europlast India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ananta Drugs And Pharmaceuticals Private LimitedActive 23 years 10 monthsSanjay Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pacific Europlast India?
Unlock and access historical data on people associated with Pacific Europlast India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pacific Europlast India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pacific Europlast India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
